Skip to main content
[Preprint]. 2023 May 11:2023.05.08.23289640. [Version 1] doi: 10.1101/2023.05.08.23289640

Table 2.

Demographics of serum/plasma PhIP-seq study cohorts

Entire Cohort
Group, n

Control (Blood Bank Samples) 138
RA (without symptoms of lung disease) 15
ILD 398
Demographics for ILD group

Diagnosis, n

Idiopathic Pulmonary Fibrosis 102
Hypersensitivity Pneumonitis 70
Connective Tissue Disease-ILD 80
Unknown Connective Tissue Disease ILD 27
Sarcoidosis 32
Others1 87

Age, median (range)

Idiopathic Pulmonary Fibrosis 72 (43 – 90)
Hypersensitivity Pneumonitis 67 (31 – 84)
Connective Tissue Disease-ILD 61 (27 – 81)
Unknown Connective Tissue Disease ILD 64 (37 – 80)
Sarcoidosis 58 (29 – 75)
Others1 66 (29 – 85)

Sex, n

Female 195
Male 194
Not Available 9

Self-identified Race/Ethnicity, n

White 275
Black 39
Hispanic, Latin(o/a/x)2 34
Asian 28
American Indian 3
Other Identity 2
Not Available 17

ILD cohort consisted of a combination of n=189 from University of Chicago and n=209 from UCSF.

1

Others reflected a constellation of diagnoses not otherwise represented on this table and were a heterogeneous group of disorders (e.g. asbestosis, unclassifiable ILD, etc.)

2

Hispanic, Latin(o/a/x) indicated individuals who did not self-identify with race but identified with ethnicity as Hispanic or Latino at UCSF and those who identified as Hispanic at University of Chicago. Individuals without known race, ethnicity, or sex information were categorized as Not Available. Data on race or ethnicity was not available for 138 subjects used as the screening reference (control) group.